Tubidy

Shuren Fda

What is CDRH doing to accelerate the regulatory pathway for innovative medical technologies?

What is CDRH doing to accelerate the regulatory pathway for innovative medical technologies?

6:16 |
EP. 2 Jeffrey Shuren on FDA-sponsor interactions: Where they’ve been and where they’re going

EP. 2 Jeffrey Shuren on FDA-sponsor interactions: Where they’ve been and where they’re going

29:01 |
FDA official testifies regarding laboratory developed tests (LDTs)

FDA official testifies regarding laboratory developed tests (LDTs)

4:02 |
Jeffrey Shuren, director of FDA's CDRH will make end year (2011) announcement on amalgam rule

Jeffrey Shuren, director of FDA's CDRH will make end year (2011) announcement on amalgam rule

4:36 |
Total Product Lifecycle Advisory Program (TAP) Engagement with Device Developers

Total Product Lifecycle Advisory Program (TAP) Engagement with Device Developers

4:16 |
CDRH Center Director Jeff Shuren on why FDA invests in MDIC

CDRH Center Director Jeff Shuren on why FDA invests in MDIC

0:56 |
Reporting on MassMEDIC's Regulatory Roundup

Reporting on MassMEDIC's Regulatory Roundup

7:32 |
Did FDA's Jeffrey Shuren lie under oath about Google-backed 23andMe?

Did FDA's Jeffrey Shuren lie under oath about Google-backed 23andMe?

4:58 |
MDUFA IV and Beyond: Video Reports

MDUFA IV and Beyond: Video Reports

9:24 |
US FDA CDRH Director Jeff Shuren presents at the MDIC 2015 Annual Public Forum

US FDA CDRH Director Jeff Shuren presents at the MDIC 2015 Annual Public Forum

10:51 |
Jeff Shuren of the FDA at the 2023 Utah Life Sciences Summit

Jeff Shuren of the FDA at the 2023 Utah Life Sciences Summit

45:24 |
FDASIA Briefing

FDASIA Briefing

40:53 |
FDA Roundtable

FDA Roundtable

48:31 |
Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 1 - Part 1

Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 1 - Part 1

1:42:05 |
07/18/2018 - Session VI: Shuren

07/18/2018 - Session VI: Shuren

13:41 |
What's most important for innovators to understand about FDA's new mobile health guideline?

What's most important for innovators to understand about FDA's new mobile health guideline?

3:01 |
Safety Signal Transparency: Using the Power of Data

Safety Signal Transparency: Using the Power of Data

34:48 |
Conversation with Dr. Jeff Shuren

Conversation with Dr. Jeff Shuren

48:09 |
Medtech Insight interviews CDRH Director Jeff Shuren

Medtech Insight interviews CDRH Director Jeff Shuren

15:15 |
Bilirakis Questions FDA Regarding Lab Developed Tests & Healthcare Costs

Bilirakis Questions FDA Regarding Lab Developed Tests & Healthcare Costs

4:56 |
← Previous
29
Next →